What analysts say:
- Buy, sell, or hold?: Analysts are bullish on Gentex as five analysts rate it as a buy and only one analyst rates it as a sell. Analysts don't like Gentex as much as competitor Lear overall. That rating hasn't budged in three months as analysts have remained unchanged in their opinion of the stock.
- Revenue forecasts: On average, analysts predict $260.6 million in revenue this quarter. That would represent a rise of 26% from the year-ago quarter.
- Wall Street earnings expectations: The average analyst estimate is earnings of $0.29 per share. Estimates range from $0.28 to $0.30.
What our community says:
CAPS All-Stars are solidly backing the stock with 93.1% granting it an outperform rating. The community at large backs the All-Stars with 89.1% giving it a rating of outperform. Fools have embraced Gentex, though the message boards have been quiet lately with only 46 posts in the past 30 days. Though still bullish, the CAPS rating of four out of five stars for Gentex is a bit more pessimistic than the community assessment.
Gentex's profit has risen year over year by an average of 27.4% over the past five quarters.
We can help you keep tabs on your companies with My Watchlist, our free, personalized service. Add Gentex now.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.